Advertisement · 728 × 90

Posts by Turvey Lab

Congratulations to Dr. Darlene Dai, Dr. Stuart Turvey and Dr. Charisse Petersen on the study!

@turveylab.bsky.social

1 day ago 3 1 0 0

New research from BCCHR, uses longitudinal data from the CHILD Cohort Study, to show that breastfeeding acts as a shield, protecting the infant microbiota from many different exposures well into early childhood. The impact is especially clear among children from lower socioeconomic status.

1 day ago 4 1 1 0

I totally agree. It is my mission to always connect with bedside care teams rather than hiding away on my computer. This is where I find the joy of medicine! But maybe I am just old?

1 day ago 0 0 0 0

Thanks Dawn!

4 days ago 1 0 0 0

Our new paper is out!

4 days ago 1 0 0 0
Preview
Breastfeeding may lessen socioeconomic disparities in child health through differences in the infant gut microbiome Darlene Dai, Charisse Petersen, Stuart Turvey, and colleagues report that breastfeeding may mitigate the adverse effects of socioeconomic disadvantage on early risk factors for non-communicable diseases. The authors link this effect to differences in infant gut microbiota, including enrichment of Bifidobacterium infantis, highlighting potentially modifiable pathways underlying intergenerational health inequities.

Online now: Breastfeeding may lessen socioeconomic disparities in child health through differences in the infant gut microbiome

1 week ago 4 4 1 2

Thanks for noticing @labwaggoner.bsky.social !

4 days ago 0 0 0 0
Post image

Breastfeeding may lessen socioeconomic disparities in child health through differences in the infant gut microbiome @cp-cellrepmed.bsky.social @turveylab.bsky.social
@bcchresearch.bsky.social
www.cell.com/cell-reports...

1 week ago 7 3 2 0

Totally agree with this!

2 weeks ago 2 0 0 0

Bravo! Really important work.

3 weeks ago 0 0 1 0
Advertisement
Post image

Monogenic disorders of the IRF transcription factors. Review by Mattison Stojcic, Pariya Yousefi, Catherine Biggs, and Stuart Turvey @turveylab.bsky.social: rupress.org/jem/article/...

📘 In our #InnateImmunity collection: rupress.org/jem/collecti...

#KSInnateImmune26

1 month ago 1 1 0 0

You are kind to say that Dawn!

1 month ago 2 0 0 0
Preview
© CBC/Radio-Canada 2026. All rights reserved.

Fantastic interview with Ty Sperle and BCCHR's Dr Stuart Turvey (@turveylab.bsky.social) on a successful gene treatment for a rare immune disorder on The Current with Matt Galloway this morning.

www.cbc.ca/listen/live-...

1 month ago 3 3 0 0
Preview
B.C. man cured of rare disease in world-first for new gene-editing technology Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

1 month ago 11 3 0 1
Preview
In world-first, B.C. teen cured of rare genetic disease The 19-year-old, who lives in Kelowna, had been diagnosed with chronic granulomatous disease around age five, compromising his immune system

In a world first, B.C. teen cured of rare disease through gene editing treatment. Ty Sperle cured of chronic granulomatous disease with a treatment known as “prime editing,” by Brenna Owen www.theglobeandmail.com/canada/briti... via @theglobeandmail.com

1 month ago 33 14 0 2
Preview
© CBC/Radio-Canada 2026. All rights reserved.

Great to talk with Matt Galloway on CBC The Current this morning about successful gene therapy for a human immune defect.

The Current with Matt Galloway - March 9, 2026: How a gene edit gave a B.C teen his life back.

www.cbc.ca/listen/live-...

@mattgalloway.bsky.social @bcchresearch.bsky.social

1 month ago 12 4 3 0
Post image

Learn how the early life #microbiome shapes immune programming in childhood #asthma and #allergies in this review from Stuart Turvey and colleagues mucosalimmunology.org/article/S193...

1 year ago 6 2 0 1
Post image

A multimorphic variant in ThPOK causes #InbornErrorsOfImmunity with T cell defects and #fibrosis, say Maryam Vaseghi-Shanjani, Mehul Sharma, Catherine M. Biggs, Stuart E. Turvey et al. @TurveyLab.bsky.social
rupress.org/jem/article/...

10 months ago 3 1 0 2
Advertisement
Post image

Instead of studying asthma only after children get sick, Dr. Stuart Turvey and his team at UBC have taken a different approach.

💩 By analyzing infant stool samples, researchers found differences in gut bacteria that were associated with later development of #asthma: https://bit.ly/4rqPbHa

1 month ago 6 1 1 1

@romberglab.bsky.social!!

1 month ago 3 0 0 0
Post image

What can dirty diapers tell us about #asthma?
Clues from the gut #microbiome are reshaping how we understand pediatric asthma and allergies!
Breastfeeding, B. infantis, and early microbial exposures matter. 2025 @washumedicine.bsky.social Pediatric
Research Retreat #Keynote by Stuart Turvey

1 year ago 3 1 1 0
Preview
B.C. man cured of rare disease in world-first for new gene-editing technology - Canada News Beep Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

B.C. man cured of rare disease in world-first for new gene-editing technology

https://www.newsbeep.com/ca/500965/

Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through…

1 month ago 1 1 0 0
Post image

This is BRILLIANT!!
B.C. teen becomes first in the world cured of rare disease using gene editing 🙏

18-year-old Ty Sperle from UBC Okanagan was Participant 1 in the trial. He had chronic granulomatous disease since age 5 and is now completely cured after the gene edit fixed his immune cells.

1 month ago 2 3 0 0
Preview
B.C. man cured of rare disease in world-first for new gene-editing technology Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

B.C. man cured of rare disease in world-first for new gene-editing technology - Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

1 month ago 3 2 1 0

Ultimate precision medicine!

Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.

Kudos to Dr. Elie Haddad for launching this trial in Canada.

@nejm.org @genomecanada.ca @genomebc.bsky.social

1 month ago 4 3 1 0
Advertisement
Preview
B.C. man cured of rare disease in world-first for new gene-editing technology Ty Sperle says he felt "insane shock" after learning he'd been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

Ty Sperle says he felt "insane shock" after learning he'd been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.

1 month ago 21 6 0 3

Ultimate precision medicine!

Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.

Kudos to Dr. Elie Haddad for launching this trial in Canada.

@nejm.org @genomecanada.ca @genomebc.bsky.social

1 month ago 1 0 0 0

Ultimate precision medicine!

Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.

Kudos to Dr. Elie Haddad for launching this trial in Canada.

@nejm.org @genomecanada.ca @genomebc.bsky.social

1 month ago 1 0 0 0
Revisiting X-linked agammaglobulinemia | Journal of Human Immunity | Rockefeller University Press Although the pathogenesis of XLA is well understood, several issues remain open for discussion. We describe several unresolved issues, including non-coding

#5 Kanegane et al review unresolved issues in the pathogenesis of X-linked agammaglobulinemia (XLA), incl. non-coding BTK variants, contiguous deletion syndrome, Helicobacter infection, non-infectious neurodegeneration, renal involvement & malignancies: rupress.org/jhi/article/...

3 months ago 6 2 0 0
Prevalence and association of type I IFN autoantibodies with clinical outcomes in critically ill Brazilian COVID-19 patients | Journal of Human Immunity | Rockefeller University Press Type I IFN autoantibodies (auto-Abs) impair antiviral immunity and are associated with severe COVID-19. This study reveals a 6.7% prevalence of auto-Abs in

#4 Type I IFN autoantibodies (auto-Abs) are associated w/ severe #COVID19. Peduti et al. reveal a 6.7% prevalence of auto-Abs in critically ill Brazilian patients, predominantly affecting older individuals, and links their presence to worse clinical outcomes: rupress.org/jhi/article/...

3 months ago 4 2 0 0